Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
abscess, intracerebral
abscess, intracerebral, multiple
abscess, intracranial-fungal
acute disseminated encephalomyelitis
advances in neurology
adverse drug reaction
alemtuzumab
Alzheimer's disease
Alzheimer's disease, diagnosis of
Alzheimer's disease, preclinical
amyloid beta protein
amyloid imaging
amyloid plaques
anatomy of
anemia
aneurysm
aneurysm, fusiform
aneurysm, intracranial
apolipoprotein E
aspergillosis
asymptomatic
ataxia
attention deficit disorder with hyperactivity
autoimmune disease
axonal degeneration
Barkhof MR criteria for MS
basal cistern
basal ganglia
basal ganglia, degeneration
basal ganglia, hemorrhage
basal ganglia, lesion of
basal ganglia, lesion, bilateral
behavioral disorder
BENEFIT study
biologic markers
blacks
bone marrow transplantation
bradykinesia
brain atrophy
brain volume
brainstem, infarction of
carotid artery disease
carotid artery occlusion, intracranial
CAT scan, angiography
CAT scan, emission
CAT scan, emission, abnormal
caudate nucleus
caudate nucleus, atrophy
celiac disease, adult
cerebellar infarction
cerebellar lesion
cerebellar vermis
cerebellum
cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy
cerebral cortex
cerebral cortical atrophy
cerebral embolism, mechanical extraction
cerebral hemisphere left-right asymmetry
cerebral infarction
cerebral infarction, hemorrhagic
cerebral ischemia
cerebrospinal fluid
cerebrospinal fluid, biochemical markers of CNS disease
cerebrospinal fluid, morphometry
cerebrospinal fluid, oligoclonal IgG in
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, prognosis in
cerebrovascular accident, severity
cerebrovascular accident, surgical treatment of
cerebrovascular accident, thrombolytic agents in treatment
cerebrovascular accident, time to treatment
cerebrovascular accident, volume
cerebrovascular disease, natural history of
chemotherapy, CNS treatment and complications with
children
chromosomal abnormality
cigarette smoking
cognition
complications
cop 1
craniectomy, decompressive
deep gray nuclei
dementia
dementia, diagnostic evaluation of
dementia, early detection
differential diagnosis
disability rating scale, neurological
disability, neurological
door to needle time
echolalia
efficacy
encephalitis
encephalitis, bornavirus
encephalitis, viral
encephalopathy, post traumatic
endemic area
endovascular therapy
epidemiology of neurology
facial nerve palsy
familial
fever
fibrinolytic agents
fibrinolytic agents, complications
fingolimod
florbetapir
flu-like illness
fragile-X syndrome
frontal lobe, anatomy and physiology
frontal lobe, atrophy
frontal lobe, behavior with disease of
frontal lobe, lesion of
frontal lobe, pathologic signs of
fungal infection, CNS
gadolinium
gene
genetic neurologic disorders
Gilles de la Tourette syndrome
gray matter
haloperidol
head injury
head injury, prognosis in
headache
hemoglobin abnormality, neurologic complications of
herpes virus infection
hippocampal atrophy
hippocampus
Huntington's chorea
Huntington's chorea, presymptomatic detection of
hydrocephalus
hydrocephalus, exvacuo
hydrocephalus, normal pressure
immunocompetent
immunomodulation
immunosuppression
immunosuppressive agents
infection
intellectual deficit
intellectual deterioration
interferon
interferon beta 1-a
interferon beta 1-b
intracerebral hemorrhage
intracerebral hemorrhage, clot evacuation
intracerebral hemorrhage, location of
intracerebral hemorrhage, treatment of
iron, brain
ischemic core
ischemic penumbra
Jakob-Creutzfeldt disease
lead and the nervous system
lead poisoning
lenticular nucleus, lesion of
lenticular nucleus, lesion of, bilateral
leptin
Lesch-Nyhan syndrome
leukemia
limbic system
liver function enzymes
lobar atrophy
magnetic transfer imaging
McDonald criteria for MS
medulla oblongata, infarction of
memory, impairment of
mesial temporal sclerosis
mesial temporal sclerosis, bilateral
middle cerebral artery, occlusion of
mild cognitive impairment
mimics
misdiagnosis
mortality
MRI
MRI, abnormal
MRI, ADC maps
MRI, black holes on
MRI, cerebrovascular disease
MRI, contrast enhanced
MRI, demyelinating disease
MRI, diffusion tensor
MRI, diffusion weighted
MRI, disappearing lesion on
MRI, early changes in CVA
MRI, fast
MRI, field strength, high
MRI, functional
MRI, gradient-echo
MRI, head injury
MRI, high signal foci on
MRI, high signal intensity of basal ganglia
MRI, hypointense signal foci on
MRI, lesion burden
MRI, magnetization transfer sequence
MRI, morphometyry
MRI, negative
MRI, perfusion
MRI, protocol
MRI, ring sign
MRI, serial
MRI, spinal cord
MRI, susceptibility weighted
MRI, T1 weighted high signal foci
MRI, target sign
MRI, volumetry
MRI, voxel-based morphometry
MRS
multiple sclerosis
multiple sclerosis, aggressive
multiple sclerosis, conversion to clinically definite
multiple sclerosis, diagnosis of
multiple sclerosis, diagnostic criteria
multiple sclerosis, differential diagnosis of
multiple sclerosis, disability status scale
multiple sclerosis, etiology of
multiple sclerosis, misdiagnosis
multiple sclerosis, monosymptomatic
multiple sclerosis, plaque
multiple sclerosis, prognosis
multiple sclerosis, relapsing
multiple sclerosis, secondary progressive
multiple sclerosis, treatment of
multiple sclerosis, treatment of, first attack
multiple sclerosis, worsening
multiple system atrophy
myelitis, longitudinal
myelomalacia
neuroaxonal degeneration
neurochemistry
neurofilaments
neurologic consultation
neurologic disease, diagnoses of
neurologic symptoms
neuromyelitis optica (Devic's disease)
neuropathology
neurotoxic
neurotoxicity, acute
NIH stroke scale
Notch3 gene
obsessive-compulsive disorder
old age, neurology of
optic neuritis
palilalia
Parkinson disease
perihippocampal fissure
pimozide
Pittsburgh Compound B
pleocytosis of cerebrospinal fluid
pons, infarction of
posterior cerebral artery territory infarction
practice guidelines
preclinical
prevention of neurologic disorders
prognosis
progressive supranuclear palsy
psychological testing
psychological testing, neurologic problems
race
Rankin score
rapidly fatal neurologic illness
rapidly progressing neurologic illness
reperfusion
Retriever Device
Rett's syndrome
revascularization, surgical
review article
risk factors
safety
schizophrenia
screening
seizure
seizure, focal
seizure, focus
seizure, intractable
seizure, intractable, treatment of
seizure, prevention of
seizure, psychomotor-temporal lobe
seizure, surgical treatment of
seizure, treatment of
sickle cell disease
single photon emission computed tomography
solitaire device
stem cell transplantation
steroid
steroid therapy, CNS treatment and complications with
striatum, lesion of
stroke disability scale
stroke, progression of
sun exposure
SWIFT PRIME Trials
sylvian fissure
T1 black holes
tau protein
temporal horn, enlarged
temporal lobe
temporal lobe, anatomy and physiology
temporal lobe, atrophy
temporal lobectomy
teriflunomide
thalamus, lesion of
thalamus, lesion of-bilateral
thrombectomy
thrombocytopenia
tic
tissue plasminogen activator, intravenous
tractography
treatment of neurologic disorder
Turner's syndrome
twins
ultraviolet light
urinary tract infection
vaccine
ventricular enlargement
vertebral-basilar insufficiency
viral infection
visual loss
vitamin D
weight loss
white matter disease
white matter tracts
white matter, dirty-appearing
Showing articles 350 to 400 of 13413 << Previous Next >>

Monoclonal Antibody Therapies and Neurologic Disorders
Arch Neurol 65:1162-1165, Novack,J.C.,et al., 2008

Glatiramer Acetate--Associated, CD30+, Primary, Cutaneous, Anaplastic Large-Cell Lymphoma
Arch Neurol 65:1378-1379, Madray,M.M.,et al, 2008

Mitoxantrone as Induction Treatment in aggressive Relapsing Remitting Multiple Sclerosis: Treatment Response Factors in a 5 Year Follow-up Observational Study of 100 Consecutive Patients
JNNP 79:52-56, Le Page,E.,et al, 2008

Unexpected Multiple Sclerosis: Follow-Up of 30 Patients With Magnetic Resonance Imaging and Clinical Conversion Profile
JNNP 79:195-198,112, Lebrun,C.,et al, 2008

B-Cell Depletion with Rituximab in Relapsing-Remitting Multiple Sclerosis
NEJM 358:676-688, Hauser,S.L.,et al, 2008

Melanoma Complicating Treatment with Natalizumab for Multiple Sclerosis
NEJM 358:647-648, Mullen,J.T.,et al, 2008

Postwithdrawal Rebound Increase in T2 Lesional Activity in Natalizumab-Treated MS Patients
Neurol 70:1150-1151,1073, Vellinga,M.M.,et al, 2008

Do Oligoclonal Bands Add Information to MRI in First Attacks of Multiple Sclerosis?
Neurol 70:1079-1083,1059, Tintore,M.,et al, 2008

Interferon �-Associated Retinopathy in Patients Treated for Multiple Sclerosis
Neurol 70:1153-1155, Folden,D.V.,et al, 2008

Sporadic Adult-Onset Leukoencephalopathy with Neuroaxonal Spheroids Mimicking Cerebral MS
Neurol 70:1128-1133, Keegan,B.M.,et al, 2008

Anti-NMDA-Receptor Encephalitis: Case Series and Analysis of the Effects of Antibodies
Lancet Neurol 7:1091-1098, Dalmau,J.,et al, 2008

Bal�s Disease Showing Benign Clinical Course and Co-Existence with Multiple Sclerosis-Like Lesions in Chinese
Multiple Sclerosis 14:418-424, Wang,C.,et al, 2008

Anti-NMDA-Receptor Encephalitis: Case Series and Analysis of the Effects of Antibodies
Lancet Neurol 7:1091-1098, Dalmau,J.,et al, 2008

Non-Communicating Syringomyelia: A Feature of Spinal Cord Involvement in Multiple Sclerosis
Brain 131:1776-1782, Weier,K.,et al, 2008

Non-Paraneoplastic Limbic Encephalitis Associated with Anti-Glutamic Acid Decarboxylase Antibodies
J Neuroimmunol 199:155-159, Mata,S.,et al, 2008

An Approach to the Diagnosis of Acute Transverse Myelitis
Semin Neurol 28:105-120, Jacob, A.,et al, 2008

Course and Outcome of Acute Limbic Encephalitis With Negative Voltage-Gated Potassium Channel Antibodies
JNNP 78:391-394, Samarasekera,S.R., et al, 2007

How Effective Are Disease-Modifying Drugs in Delaying Progression in Relapsing-Onset MS?
Neurol 69:1498-1507, Brown,M.G.,et al, 2007

Primary Central Nervous System Vasculitis: Analysis of 101 Patients
Ann Neurol 62:442-451,430, Salvarani,C.,et al, 2007

Daclizumab Phase II Trial in Relapsing and Remitting Multiple Sclerosis
Neurol 69:785-789, Rose,J.W.,et al, 2007

Guidelines For Using Proton MR Spectroscopy in Multicenter Clinical MS Studies
Neurol 69:1942-1952, De Stefano,N.,et al, 2007

Health-Related Quality of Life in Multiple Sclerosis: Effects of Natalizumab
Ann Neurol 62:335-346, Rudick,R.A.,et al, 2007

Quantitative Assessment of Iron Accumulation in the Deep Gray Matter of Multiple Sclerosis by Magnetic Field Correlation Imaging
AJNR 28:1639-1644, Ge,Y.,et al, 2007

Acute Fulminant Demyelinating Disease: A Descriptive Study of 60 Patients
Arch Neurol 64:1426-1432, de Seze,J.,et al, 2007

Balos Concentric Sclerosis Presenting as a Stroke-Like Syndrome
Nat Clin Pract Neurol 3:349-354, Mowry,E.M.,et al, 2007

Clinicopath Conf., Paraneoplastic Cerebellar Degeneration Due to Anti-Yo Antibodies From Breast Cancer
NEJM 356:612-620, Case 4-2007, 2007

Diagnosis and Treatment of Neuromyelitis Optica
The Neurologist 13:2-11, Wingerchuk,D.M., 2007

Thalamic Atrophy and Cognition in Multiple Sclerosis
Neurol 69:1213-1223, Houtchens,M.K.,et al, 2007

Natalizumab (Tysabri) Treatment for Relapsing Multiple Sclerosis
The Neurologist 13:182-187, Johnson,K.P., 2007

Effect of Early Verus Delayed Interferon Beta-1b Treatment on Disability After a First Clinical Event Suggestive of Multiple Sclerosis: A 3-Year Follow-Up Analysis of the BENEFIT Study
Lancet 370:389-397, Kappos,L.,et al, 2007

What Do We Really See When We Look at Magnetic Resonance Images?
Ann Neurol 62:207-208, Filippi,M. &Hartung,H.-P., 2007

Natalizumab for Multiple Sclerosis
NEJM 356:2622-2629, Ransohoff,R.M., 2007

Sexual Function in Men and Women With Neurological Disorders
Lancet 369:512-525, Rees,P.M.,et al, 2007

Randomized, Double-Blind, Dose-Comparison Study of Glatiramer Acetate in Relapsing-Remitting MS
Neurol 68:939-944, Cohen,J.A.,et a, 2007

Reactivation of JC Virus and Development of PML in Patients With Multiple Sclerosis
Neurol 68:985-990, Khalili,K.,et al, 2007

Neutralizing Antibodies to Interferon Beta: Assessment of Their Clinical and Radiographic Impact: An Evidence Report
Neurol 68:977-984, Goodin,D.S.,et al, 2007

Natalizumab Reduces Visual Loss in Patients with Relapsing Multiple Sclerosis
Neurol 68:1299-1302, Balcer,L.J.,et al, 2007

Neurologic Complications of Gastric Bypass Surgery for Morbid Obesity
Neurol 68:1843-1850, Juhasz-Pocsine,K.,et al, 2007

Quantifying the Risks and Benefits of Natalizumab in Relapsing Multiple Sclerosis
Neurol 68:1524-1528, Dorsey,E.R.,et al, 2007

Mitoxantrone for Multiple Sclerosis Causing Acute Lymphoblastic Leukemia
Neurol 68:1630-1631, Cartwright,M.S.,et al, 2007

MRI Outcomes in a Placebo-Controlled Trial of Natalizumab in Relapsing MS
Neurol 68:1390-1401, Miller,D.H.,et al, 2007

Asymmetric Cerebellar Ataxia and Limbic Encephalitis as a Presenting Feature of Primary Sjogrens Syndrome
J Neurol 254:1609-1611, Collison,K. and Rees,J., 2007

Differential Diagnosis of Bilateral Thalamic Lesions
Clin Neuroradiol 17:3-22, Linn,J.,et al, 2007

Spinal dural arteriovenous fistulas: a congestive myelopathy that initially mimics a peripheral nerve disorder
Brain 129:3150-3164, Jellema, K., et al, 2006

Dementia and White-Matter Demyelination in Young Patient With Neurosyphilis
Lancet:368:2258, Brinar,V.V. &Habek,M., 2006

Infusion-Related Hypersensitivity Reactions During Natalizumab Treatment
Neurol 67:1717-1718, Phillips,J.T.,et al, 2006

In Vivo Detection of Cortical Plaques by MR Imaging in Patients with Multiple Sclerosis
AJNR 27:2161-2167, Bagnato,F.,et al, 2006

Pathologic Laughing and Intractable Hiccups Can Occur Early in Multiple Sclerosis
Neurol 67:1684-1686, de Seze,J.,et al, 2006

High-Dose Cyclophosphamide for Moderate to Severe Refractory Multiple Sclerosis
Arch Neurol 63:1388-1393, Gladstone,D.E.,et al, 2006

Treatment With Interferon beta-1b Delays Conversion to Clinically Definite and McDonald MS in Patients With Clinically Isolated Syndromes
Neurol 67:1242-1249, Kappos,L.,et al, 2006



Showing articles 350 to 400 of 13413 << Previous Next >>